MSD (Sweden)

MSD (Sweden)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for MSD (Sweden), Sweden, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

74%


Total
Publications

119


Total Open
Publications

88


Total
Citations

8.9K


Open Access
Percentage

74%


Total
Publications

119


Total Open
Publications

88


Total
Citations

8.9K

Wikipedia

Website

download

Breakdown

29% 34% 11% 26%

Publisher Open

29%

Both

34%

Other Platform Open

11%

Closed

26%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

38%OA Journal

OA Journal 38%

28

Hybrid 45%

34

No Guarantees 17%

13

Other Platform Open

Domain 72%

39

Institution 44%

24

Other Internet 17%

9

Preprint 7%

4

Public 4%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
39
Europe PMC
Domain
12
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
10
KTH Royal Institute of Technology - KTH Publication Database DiVA
Other Internet
6
Erasmus University Rotterdam - EUR Research Repository
Institution
5
DiVA.org
Other Internet
5
Linkoping University - DiVA
Institution
3
Åbo Akademi University - AboCRIS
Institution
2
Uppsala University - Uppsala University Publications
Institution
2
Umeå University - DiVA at Umeå University
Institution
2
1 / 4

Data updated 8 December 2024

Share

Share

Share